| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdcc408bc9b5b3edb05b961d5186121d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f0ed84ebbe977c074935588cd071201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-207 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 |
| filingDate |
2004-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb626132231a97e2600bc8e59c846ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de0acdba530ad75775ebc7b8debee294 |
| publicationDate |
2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004091558-A2 |
| titleOfInvention |
Compounds for stimulating and for inhibiting melanin formation, and methods for screening these compounds |
| abstract |
Trisubstituted triazine compounds are screened for pigment stimulating ability or pigment inhibiting ability.Triazine compounds which bind mitochondrial ATPase have been found to increase melanin in the skin or hair. Other compounds, which interact with mitochondrial Atpase like oligomycin and aurovertin also promote pigmentation. Compounds found to be active are used for screening for other active compounds and other potential drug targets.Accordingly, prohibitin has been found to be involved in the pigmentation processes. Active compounds are used for increasing melanin in the skin or hair, or for decreasing melanin in the skin or hair. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021260667-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007060256-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7592451-B2 |
| priorityDate |
2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |